XML 19 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2017
Oct. 02, 2016
Oct. 01, 2017
Oct. 02, 2016
Income Statement [Abstract]        
Revenues [1] $ 13,168 $ 13,045 $ 38,843 $ 39,196
Costs and expenses:        
Cost of sales [1],[2] 2,847 3,085 7,980 9,111
Selling, informational and administrative expenses [1],[2] 3,500 3,559 10,233 10,414
Research and development expenses [1],[2] 1,859 1,881 5,346 5,360
Amortization of intangible assets [1] 1,177 968 3,571 2,934
Restructuring charges and certain acquisition-related costs [1] 149 531 377 988
Other (income)/deductions––net [1] 51 1,417 (16) 2,815
Income from continuing operations before provision for taxes on income [1],[3] 3,585 1,604 11,351 7,575
Provision for taxes on income [1],[4] 727 249 2,287 1,109
Income from continuing operations [1],[4],[5] 2,858 1,355 9,064 6,465
Discontinued operations––net of tax [1] 0 0 1 0
Net income before allocation to noncontrolling interests [1],[4],[6],[7] 2,858 1,355 9,066 [8] 6,465 [8]
Less: Net income attributable to noncontrolling interests [1] 18 0 32 25
Net income attributable to Pfizer Inc. [1],[4] $ 2,840 $ 1,355 $ 9,034 $ 6,440
Earnings per common share––basic:        
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share) [1],[4] $ 0.48 $ 0.22 $ 1.51 $ 1.06
Discontinued operations––net of tax (in dollars per share) [1],[4] 0 0 0 0
Net income attributable to Pfizer Inc. common shareholders (in dollars per share) [1],[4] 0.48 0.22 1.51 1.06
Earnings per common share––diluted:        
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share) [1],[4] 0.47 0.22 1.49 1.04
Discontinued operations––net of tax (in dollars per share) [1],[4] 0 0 0 0
Net income attributable to Pfizer Inc. common shareholders (in dollars per share) [1],[4] $ 0.47 $ 0.22 $ 1.49 $ 1.04
Weighted-average shares––basic [1] 5,951 6,066 5,972 6,095
Weighted-average shares––diluted [1],[4],[5] 6,041 6,150 6,057 6,175
Cash dividends paid per common share (in dollars per share) [1] $ 0.32 $ 0.30 $ 0.96 $ 0.90
[1] Amounts may not add due to rounding.
[2] Excludes amortization of intangible assets, except as disclosed in Note 9A. Identifiable Intangible Assets and Goodwill: Identifiable Intangible Assets.
[3] Income from continuing operations before provision for taxes on income. IH’s earnings in the third quarter and first nine months of 2017 include dividend income of $54 million and $211 million, respectively, from our investment in ViiV. For additional information, see Note 4.
[4] Amounts for the three and nine months ended October 2, 2016 have been revised from previously reported amounts to reflect the adoption of a new accounting standard in the fourth quarter of 2016, as of January 1, 2016. For additional information, see Note 1B. Basis of Presentation and Significant Accounting Policies––Adoption of New Accounting Standards.
[5] Amounts for the third quarter and first nine months ended October 2, 2016 have been revised from previously reported amounts to reflect the adoption of a new accounting standard in the fourth quarter of 2016, as of January 1, 2016, that requires, when applying the treasury stock method for shares that could be repurchased, that the assumed proceeds no longer include the amount of excess tax benefit (see Note 1B).
[6] Amounts may not add due to rounding.
[7] Amounts may not add due to rounding.
[8] Amounts for the three and nine months ended October 2, 2016 have been revised from previously reported amounts to reflect the adoption of a new accounting standard in the fourth quarter of 2016, as of January 1, 2016. For additional information, see Note 1B. Basis of Presentation and Significant Accounting Policies: Adoption of New Accounting Standards.